Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: Baseline diagnosis and the prediction of MCI outcome

International Journal of Geriatric Psychiatry

Volumn 30, Issue 2, 2015, Pages 192-200

  Varon, Daniel ^a,b   Barker, Warren ^a   Loewenstein, David ^c   Greig, Maria ^a   Bohorquez, Adriana ^a   Santos, Isael ^a   Shen, Qian ^a   Harper, Molly ^a   Vallejo Luces, Tatiana ^a   Duara, Ranjan ^a,b,c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's; Atrophy; Entorhinal cortex; Hippocampus; MCI; MRI

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; BRAIN CORTEX ATROPHY; BRAIN SIZE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT COUNSELING; PHASE 1 CLINICAL TRIAL; PHYSICIAN; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE; VISUAL RATING SYSTEM; ATROPHY; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; CASE-CONTROL STUDIES; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; PREDICTIVE VALUE OF TESTS;

EID: 84921025306     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4126     Document Type: Article

References (32)

1. Albert MS, Dekosky ST, Dickson D, et al. 2011. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 270-279.
2. Bakkour A, Morris JC, Dickerson BC. 2009. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 72: 1048-1055.
3. Berg L. 1988. Clinical Dementia Rating (CDR). Psychopharmacol Bull 24: 637-639.
4. Boutet C, Chupin M, Colliot O, et al. 2012. Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease? Neuroradiology 54: 1321-1330.
5. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer's-related changes. Acta Neuropathol (Berl) 82: 239-259.
6. Bresciani L, Rossi R, Testa C, et al. 2005. Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry. Aging Clin Exp Res 17: 8-13.
7. Desikan RS, Cabral HJ, Settecase F, et al. 2010. Automated MRI measures predict progression to Alzheimer's disease. Neurobiol Aging 31: 1364-1374.
8. Devanand DP, Pradhaban G, Liu X, et al . 2007. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68: 828-836.
9. Duara R, Loewenstein DA, Potter E, et al. 2008. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer's disease. Neurology 71: 1986-1992.
10. Eggert LD, Sommer J, Jansen A, Kircher T, Konrad C. 2012. Accuracy and reliability of automated gray matter segmentation pathways on real and simulated structural magnetic resonance images of the human brain. PLoS ONE 7: e45081.
11. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
12. Geuze E, Vermetten E, Bremner JD. 2005. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry 10: 160-184.
13. Jack CR, Knopman DS, Jagust WJ, et al. 2013. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12: 207-216.
14. Jauhiainen AM, Pihlajamäki M, Tervo S, et al. 2009. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment. Hippocampus 192: 166-175.
15. Killiany RJ, Hyman BT, Gomez-Isla T, et al. 2002. MRI measures of entorhinal cortex vs. hippocampus in preclinical AD. Neurology 58: 1188-1196.
16. Lehmann M, Koedam EL, Barnes J, et al. 2013. Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiol Aging 34: 73-82.
17. Liu Y, Mattila J, Ruiz MAM, et al. 2013. Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted PredictAD tool. PLoS ONE 8: e55246.
18. Loewenstein DA, Acevedo A, Potter E, et al. 2009. Severity of medial temporal atrophy and amnestic mild cognitive impairment: selecting type and number of memory tests. Am J Geriatr Psychiatry 17: 1050-1058.
19. Murray ME, Graff-Radford NR, Ross OA, et al. 2011. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10: 785-796.
20. Pereira JB, Cavallin L, Spulber G, Aguilar C, et al. 2014. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med 275: 317-330.
21. Raji CA, Lopez OL, Kuller LH, et al. 2012. White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 33: 834.e7-834.e16.
22. Rey A. 1964. L'examen clinique en psychologie'. Presses Univeritaires de France: Paris.
23. Scheltens PH, Leys D, Barkhof F, et al. 1992. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal aging: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55: 967-972.
24. Scheltens P, Launer LJ, Barkhof F, et al. 1995. Inter-observer reliability of visual assessment of hippocampal atrophy on MRI. J Neurol 242: 557-560.
25. Shen Q, Loewenstein DA, Potter E, et al. 2011. Volumetric and visual rating of MRI scans in the diagnosis of amnestic MCI and Alzheimer's disease. Alzheimers Dement 8: 399-406.
26. Sperling RA, Aisen PS, Beckett LA, et al. 2011. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging - Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7; 280-292.
27. Urs R, Potter E, Barker W, et al. 2009. Visual rating system (VRS) for assessing magnetic resonance images (MRIs): a tool in the diagnosis of MCI and Alzheimer's disease. J Comput Assist Tomogr 33: 73-78.
28. Varon D, Loewenstein DA, Potter E, et al. 2011. Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment. Dement Geriatr Cogn Disord 31: 276-283.
29. Visser PJ, Verhey FRJ, Hofman PAM, Scheltens P, Jolles J. 2002. Medial temporal lobe atrophy predicts Alzheimer 's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 72: 491-497.
30. Wahlund L-O, Julin P, Johansson S-E, et al. 2000. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 69: 630-635.
31. Wechsler D. 1987. The Wechsler Memory Scale-Revised. The Psychological Corporation: San Antonio, TX.
32. Westman E, Cavallin L, Muehlboeck J-S, et al. 2011. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS ONE 6: e22506.